How Truemed Is Incentivizing Americans to Invest in Prevention

Summary

Justin Mares, founder and CEO of Truemed, argues that the U.S. food and healthcare environment systematically produces chronic disease. He traces the problem to crop subsidies, ultra-processed foods, chemical exposure, and a system that pays for sickness rather than prevention. He explains how Truemed uses tax-free HSA/FSA dollars to fund lifestyle interventions, discusses GLP-1s as useful but insufficient, and makes the case for psychedelics and peptides as disruptive healthcare tools.

• Mares argues the U.S. food system became uniquely harmful starting in the 1970s, driven by shareholder pressure and subsidized corn, soy, and wheat.
• He says crop subsidies make unhealthy ingredients artificially cheap and are a root cause of chronic disease.
• Truemed lets qualifying people use HSA/FSA dollars for lifestyle interventions such as gyms, sleep aids, supplements, and healthier food.
• GLP-1s are viewed as interesting and useful for jumpstarting health, but not a cure-all without fixing food quality.
• Psychedelics, especially ketamine-assisted therapy, are presented as effective and underinvested mental-health treatments.
• Peptides are seen as cheap, non-patentable, human-enhancement compounds that could disrupt pharma, though more research is needed.
• Mares favors dietary experimentation and views metabolic psychiatry and community-level health interventions as underexplored.